Altay Biopharma
Altay Biopharma, also known as Altay Therapeutics, is a company that is developing a novel small molecule inhibitor (ALT-CP4) for fibrosis, which targets a cellular protein that regulates matrix deposition and immune activation.
Name
# Contributions
Last Contribution
Find more companies like Altay Biopharma
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.